276
Participants
Start Date
December 1, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Esketamine hydrochloride
Intravenous infusion of esketamine: after induction, a single dose of 0.25 mg/kg before skin incision,and continuous 0.125 mg/kg/h until 30 min before surgery was stopped.
Saline
after induction, a single intravenous infusion of an equal amount of 0.9% saline before skin incision, followed by a continuous infusion at the same rate as the test group until 30 min before surgical cessation.
Chinese PLA General Hospital
OTHER